Výsledky vyhledávání

Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain)

Autor: Ribera, A, Ferreira-Gonzalez, I, Marsal, JR, Oristrell, G, Faixedas, MT, Rosas, A, Tizon-Marcos, H, Rojas, S, Labata, C, Cardenas, M, Homs, S, Tomas-Querol, C, Garcia-Picart, J, Gomez-Hospital, JA, Pijoan, JI, Masotti, M, Mauri, J, Dorado, DG, Carvajal, C, Martinez, P, Lidon, RM, Baneras, J, Massotti, M, Jimenez, G, Hernandez, M, Regueiro, A, Basaganyas, J, Loma, P, Badosa, E, Fageda, A, Ariza, A, Garcia-Amigo, C, Cequier, A, Marin, G, Maristany, J, Montoya, V, Fernandez-Nofrerias, E, Carrillo, X, Garcia-Garcia, C, Oliete, C, Bardaji, A, Bonet-Pineda, G, Munoz, JF, Padilla, F, Baquerizo, B, Recasens, L, Gaya, AB, Worner, F, Barta, L, Agusti, M, Gene, A, Jimenez, X, Mora, A, Jimenez, J

Publikováno v: BMJ Open
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Objectives Guidelines recommending 12-month dual antiplatelet therapy (DAPT) in patients with ST-elevation acute coronary syndrome (STEACS) undergoing percutaneous coronary intervention (PCI) were published in year 2012. We aimed to describe the infl

Vyhledávací nástroje:

Upřesnit hledání